These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 15184287)

  • 21. Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy.
    Li HL; Yin R; Chen D; Liu D; Wang D; Yang Q; Dong YG
    J Cell Biochem; 2007 Apr; 100(5):1086-99. PubMed ID: 17266062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of astragalus on calcium accumulation and SERCA2a gene expression in myocardial tissues in rats with pressure overload-induced left ventricular hypertrophy].
    Su D; Xu B; Shi HL; Wu DZ; Dai YL
    Zhongguo Zhong Yao Za Zhi; 2008 Jul; 33(14):1724-7. PubMed ID: 18841778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling.
    Weisberg AD; Albornoz F; Griffin JP; Crandall DL; Elokdah H; Fogo AB; Vaughan DE; Brown NJ
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):365-71. PubMed ID: 15576638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload.
    Ruetten H; Dimmeler S; Gehring D; Ihling C; Zeiher AM
    Cardiovasc Res; 2005 Jun; 66(3):444-53. PubMed ID: 15914109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mTOR/p70S6K signal transduction pathway plays a role in cardiac hypertrophy and influences expression of myosin heavy chain genes in vivo.
    Boluyt MO; Li ZB; Loyd AM; Scalia AF; Cirrincione GM; Jackson RR
    Cardiovasc Drugs Ther; 2004 Jul; 18(4):257-67. PubMed ID: 15367823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of cardiac remodeling by pravastatin is associated with amelioration of endoplasmic reticulum stress.
    Zhao H; Liao Y; Minamino T; Asano Y; Asakura M; Kim J; Asanuma H; Takashima S; Hori M; Kitakaze M
    Hypertens Res; 2008 Oct; 31(10):1977-87. PubMed ID: 19015605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth hormone attenuates myocardial fibrosis in rats with chronic pressure overload-induced left ventricular hypertrophy.
    Moreira VO; Pereira CA; Silva MO; Felisbino SL; Cicogna AC; Okoshi K; Aragon FF; Padovani CR; Okoshi MP; Castro AV
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):325-30. PubMed ID: 19278522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic enhancement of ventricular contractility protects against pressure-overload-induced cardiac dysfunction.
    Du XJ; Fang L; Gao XM; Kiriazis H; Feng X; Hotchkin E; Finch AM; Chaulet H; Graham RM
    J Mol Cell Cardiol; 2004 Nov; 37(5):979-87. PubMed ID: 15522275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EUK-8, a superoxide dismutase and catalase mimetic, reduces cardiac oxidative stress and ameliorates pressure overload-induced heart failure in the harlequin mouse mutant.
    van Empel VP; Bertrand AT; van Oort RJ; van der Nagel R; Engelen M; van Rijen HV; Doevendans PA; Crijns HJ; Ackerman SL; Sluiter W; De Windt LJ
    J Am Coll Cardiol; 2006 Aug; 48(4):824-32. PubMed ID: 16904556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pressure overload-induced myocardial hypertrophy in mice does not require gp91phox.
    Maytin M; Siwik DA; Ito M; Xiao L; Sawyer DB; Liao R; Colucci WS
    Circulation; 2004 Mar; 109(9):1168-71. PubMed ID: 14981002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mTOR signaling pathway mediates control of ribosomal protein mRNA translation in rat liver.
    Reiter AK; Anthony TG; Anthony JC; Jefferson LS; Kimball SR
    Int J Biochem Cell Biol; 2004 Nov; 36(11):2169-79. PubMed ID: 15313464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atorvastatin slows the progression of cardiac remodeling in mice with pressure overload and inhibits epidermal growth factor receptor activation.
    Liao Y; Zhao H; Ogai A; Kato H; Asakura M; Kim J; Asanuma H; Minamino T; Takashima S; Kitakaze M
    Hypertens Res; 2008 Feb; 31(2):335-44. PubMed ID: 18360054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced cardiac hypertrophy in toll-like receptor 4-deficient mice following pressure overload.
    Ha T; Li Y; Hua F; Ma J; Gao X; Kelley J; Zhao A; Haddad GE; Williams DL; William Browder I; Kao RL; Li C
    Cardiovasc Res; 2005 Nov; 68(2):224-34. PubMed ID: 15967420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice.
    Shende P; Plaisance I; Morandi C; Pellieux C; Berthonneche C; Zorzato F; Krishnan J; Lerch R; Hall MN; Rüegg MA; Pedrazzini T; Brink M
    Circulation; 2011 Mar; 123(10):1073-82. PubMed ID: 21357822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cathepsin K knockout alleviates pressure overload-induced cardiac hypertrophy.
    Hua Y; Xu X; Shi GP; Chicco AJ; Ren J; Nair S
    Hypertension; 2013 Jun; 61(6):1184-92. PubMed ID: 23529168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ivabradine improved left ventricular function and pressure overload-induced cardiomyocyte apoptosis in a transverse aortic constriction mouse model.
    Yu Y; Hu Z; Li B; Wang Z; Chen S
    Mol Cell Biochem; 2019 Jan; 450(1-2):25-34. PubMed ID: 29790114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the estrogen/estrogen-receptor-beta axis in the genomic response to pressure overload-induced hypertrophy.
    Kararigas G; Fliegner D; Gustafsson JÅ; Regitz-Zagrosek V
    Physiol Genomics; 2011 Apr; 43(8):438-46. PubMed ID: 21325064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The chemical chaperone 4-phenylbutyric acid attenuates pressure-overload cardiac hypertrophy by alleviating endoplasmic reticulum stress.
    Park CS; Cha H; Kwon EJ; Sreenivasaiah PK; Kim DH
    Biochem Biophys Res Commun; 2012 May; 421(3):578-84. PubMed ID: 22525677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex-specific mTOR signaling determines sexual dimorphism in myocardial adaptation in normotensive DOCA-salt model.
    Gürgen D; Kusch A; Klewitz R; Hoff U; Catar R; Hegner B; Kintscher U; Luft FC; Dragun D
    Hypertension; 2013 Mar; 61(3):730-6. PubMed ID: 23339165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The mammalian target of rapamycin modulates the immunoproteasome system in the heart.
    Zhang HM; Fu J; Hamilton R; Diaz V; Zhang Y
    J Mol Cell Cardiol; 2015 Sep; 86():158-67. PubMed ID: 26239133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.